JY
PHVS icon

Jeff Yass’s Pharvaris PHVS Stock Holding History

Jeff Yass’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$595K Buy
+17,200
New +$520K ﹤0.01% 9497

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Jeff Yass's PHVS Position: Q2 2026 in Review

Jeff Yass reduced its Pharvaris (PHVS) stake by 60% in Q2 2026, selling an estimated $810K and leaving 18,202 shares worth $629K. The position accounts for ﹤0.01% of the portfolio, ranked #9364.

Jeff Yass first reported a position in PHVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.71M in Q4 2025. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Jeff Yass held 18,202 shares of Pharvaris worth $629K as of Q2 2026.
  • Jeff Yass sold 26,772 Pharvaris shares in Q2 2026, an estimated $810K.
  • Pharvaris made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9364 holding.
  • Jeff Yass first reported a position in Pharvaris in Q4 2025 and has held it in 3 quarters since.
  • Jeff Yass's Pharvaris position peaked at $1.71M in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.